Bharat Biotech Covaxin finds place in Oman list of approved COVID vaccines Ruchika Sharma29 Oct 2021 3:46 PM ISTNew Delhi: Bharat Biotech's Covaxin has been included to the approved list of COVID-19 vaccines for travel to Oman without quarantine.In a tweet,...
Pfizer, BioNTech to provide additional 50 Million Pediatric doses of COVID-19 Vaccine to US Ruchika Sharma29 Oct 2021 3:33 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. government has purchased 50 million more doses of the companies' COVID-19 vaccine....
Novavax files for COVID vaccine authorization in UK Ruchika Sharma29 Oct 2021 2:26 PM ISTGaithersburg: Novavax, Inc. has recently announced the completion of its rolling regulatory submission to the U.K. Medicines and Healthcare...
Tens of millions of JnJ COVID shots sit at Baltimore factory: Report Ruchika Sharma29 Oct 2021 10:00 AM ISTNew Delhi: An estimated 30 million to 50 million doses of Johnson & Johnson's COVID-19 vaccine made early this year sits idle in Emergent...
Merck to share molnupiravir formula with poor countries, enters agreement with MPP Ruchika Sharma28 Oct 2021 5:23 PM ISTGeneva: To ensure the affordable global access for molnupiravir, pharma giant Merck (MSD) has entered into a voluntary licencing...
Bharat Biotech US partner Ocugen files for clinical trials of Covaxin Ruchika Sharma28 Oct 2021 2:16 PM ISTMalvern: Ocugen, Inc., has announced that the company has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug...
Moderna COVID vaccine could start being used in children, teens within weeks: CEO Ruchika Sharma28 Oct 2021 10:00 AM ISTNew Delhi: Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in...
Moderna says COVID vaccine safe, protective in young children Ruchika Sharma27 Oct 2021 2:00 PM ISTNew Delhi: Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to...
Give additional information on Covaxin: WHO tells Bharat Biotech Ruchika Sharma27 Oct 2021 11:41 AM ISTThe Covaxin has demonstrated 77.8 percent effectiveness against symptomatic COVID-19 and 65.2 percent protection against the new Delta variant.
DPP4 inhibitors reduce mortality risk in COVID-19 patients with diabetes: Study MD Editorial Team27 Oct 2021 9:00 AM ISTDiabetes is one of the most significant chronic diseases that increases the severity of COVID-19 and the associated risk of mortality in the pandemic....
Covaxin, Covishield cocktail safe, says ICMR study Roshni Dhar26 Oct 2021 3:58 PM ISTA combination of Covishield and Covaxin shots is safe and, in fact, offers better immunogenicity than two doses of the same vaccine, says a limited...
India crossed 1 billion vaccination milestone Roshni Dhar26 Oct 2021 3:57 PM ISTThe country now has a strong "protective shield" of 100 crore vaccine doses to combat the biggest pandemic in 100 years, Prime Minister Narendra Modi...
